Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin)
Produktgrößen
100 ug
£635,00
CHB265-100UG
1 mg
£2295,00
CHB265-1MG
Über dieses Produkt
- SKU:
- CHB265
- Zusätzliche Namen:
- IgG1|pinatuzumab vedotin
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Pinatuzumab vedotin is an ADC consisting of a CD22-directed antibody and Monomethyl auristatin E (MMAE) used for the study of hematological malignancies.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- Siglec-2 / CD22
- Isotyp:
- IgG1
- Physischer Zustand:
- Lyophilized
- Reinheit:
- >90%
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Spezifität:
- Siglec-2 / CD22
- Lagerbedingungen:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB265